Anavex Reports Fiscal First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Noble Financial Starts Anavex Life Sciences (AVXL) at Buy, PT $16
February 7, 2017 7:27 AM ESTNoble Financial initiated coverage on Anavex Life Sciences (NASDAQ: AVXL) with a Buy rating and a price target of $16.
For an analyst ratings summary and ratings history on Anavex Life Sciences... More



